InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（2 笔）
内部人交易记录
首席财务官已披露买入
0
已披露卖出
2
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the detailed record of transactions filed by Drapkin Kimberlee C, 首席财务官. Officer active across 3 companies, notably Jounce Therapeutics, Inc.. Cumulatively, 8 filings have been recorded. Split: 0 buy · 2 sells. Total volume traded: €36k. History available since 7 January 2022. The latest transaction was disclosed on 3 June 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Drapkin Kimberlee C
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报8 总计
35,500 股0Common StockSEC:0001628280-26-041276:0
13,794 股Common StockSEC:0000950170-25-093062:0
12,500 股@ US$0.611100.0% 占其流量Common StockSEC:0000950170-25-090145:0
12,800 股0Common StockSEC:0001576885-25-000081:0
25,751 股Common StockSEC:0001640455-23-000107:0
6,315 股@ US$1.109.9% 占其流量Common StockSEC:0001640455-23-000009:0
27,500 股0Common StockSEC:0001640455-22-000018:0
4,595 股@ US$7.3082.0% 占其流量Common StockSEC:0001640455-22-000009:0
8 条申报中的 8 条
About Drapkin Kimberlee C
Drapkin Kimberlee C is Directeur financier et trésorier. She is associated with Jounce Therapeutics, Inc., where she is President, CFO and Treasurer, as well as Acumen Pharmaceuticals, Inc. and Kineta, Inc./de, where she is Director. She has 8 filings in total, and across the sampled recent filings, sales total 36211 EUR between 2022-01-11 and 2026-06-05, with the modal transaction nature listed as Attribution.
